Agenda

September 2nd & 3rd, 2009, Winnipeg, Manitoba, Canada
Agenda [432 Kb]

DAY 1 – Wednesday, September 2

8:00 am – 8:30 am	OPENING REMARKS: – (Midway Ballroom) Speaker: The Honourable Leona Aglukkaq, Minister of Health Honourable Theresa Oswald, Manitoba Minister of Health Dr. David Butler–Jones, Chief Public Health Officer, Public Health Agency of Canada Dr. Frank Plummer, Chief Science Advisor, Public Health Agency of Canada
8:30 am – 10:15 am	PLENARY SESSION 1: Overview of Severe H1N1 – (Midway Ballroom) Chair: Dr. Frank Plummer, Chief Science Advisor, Public Health Agency of Canada
	Title	Speaker
	Update and Overview on the Global H1N1 Activity and Management	Dr. Charles Penn, World Health Organization
	Update on Canadian H1N1 Epidemic	Dr. John Spika, PHAC
	Update on Manitoba H1N1 Epidemic	Dr. Joel Kettner, Manitoba Health
	Modelling the Next Wave	Dr. Babak Pourbohloul, British Columbia Centre for Disease Control
	Update on Severe Cases	Dr. Robert Fowler, University of Toronto
	Modelling of Severe Disease	Dr. Paul Smetanin, Risk Analytica Dr. David Stiff, Risk Analytica
	10–15 minute presentation plus 5 minutes for questions.
10:15 am – 10:30am	BREAK
10:30 am – 12:00 pm	PLENARY SESSION 2: Severe Disease Epidemic Narratives – (Midway Ballroom) Chair: Dr. Anand Kumar, University of Manitoba
	Title	Speaker
	Lessons Learned from Previous Pandemics	Dr. Marty Cetron, Centers for Disease Control & Prevention
	System Issues: Lessons from SARS	Dr. Alison McGeer, Mount Sinai Hospital
	Description of Clinical Management and Challenges Experienced in the Community	Dr. Adrian Robertson, Manitoba Health
	Description of Clinical Management and Challenges Experienced in Winnipeg ICUs	Dr. Anand Kumar, University of Manitoba
	10-15 minute presentation plus 5–10 minutes for questions.
12:00 pm – 1:00 pm	LUNCH
1:00 pm – 2:30 pm	PLENARY SESSION 3: Practical Aspects of Epidemic Management – (Midway Ballroom) Chair: Dr. Mike Christian, Mount Sinai Hospital
	Title	Speaker
	Shifting the Paradigm: Individual Patient vs. Population Health	Dr. Thomas Marrie, Dalhousie University
	Infection Control and Prevention	Dr. Lynn Johnston, Dalhousie University
	Antivirals, Risk Factors and Vaccination Strategies within Canada	Dr. Barb Law, PHAC
	10–15 minute presentation plus 5–10 minutes for questions.
2:30 pm – 3:00 pm	BREAK
3:00 pm – 4:00 pm	PLENARY SESSION 4: Pandemic Preparedness for Surge Capacity Management – (Midway Ballroom) Chair: Dr. Theresa Tam, PHAC
	Title	Speaker
	Federal Surge Capacity	Dr. Michael O’Connor, PHAC
	Ontario Provincial Surge Capacity	Dr. Bernard Lawless, Ministry of Health and Long Term Care (Ontario)
	Hospital/Regional Surge Capacity	Dr. Perry Gray, Health Sciences Centre
	15–20 minute presentation plus 10–15 minutes for questions.
4:00 pm – 5:00 pm	INFORMAL DISCUSSIONS FOR PROFESSIONAL GROUPS – (Midway Ballroom)
5:00 pm – 7:00 pm	RECEPTION – (Foyer)

DAY 2 – Thursday, September 3

8:30 am – 10:00 am	BREAKOUT SESSION 1 – (Midway Ballroom, East Ballroom, West Ballroom)
10:00 am – 10:30am	BREAK - (Foyer)
10:30 am – 12:00 pm	BREAKOUT SESSION 2 – (Midway Ballroom, East Ballroom, West Ballroom)
12:00 pm – 1:00 pm	LUNCH – (Foyer)
1:00 pm – 2:15 pm	PLENARY SESSION 5: H1N1 International Scope – (Midway Ballroom) Chair: Dr. Graham Tipples, Public Health Agency of Canada
	Title	Speaker
	H1N1 Update – Australia	Dr Andrew Singer, Department of Health and Ageing, Australia
	H1N1 Update – Chile	Dr. Guillermo Bugedo, Pontifical Catholic University of Chile
	10–15 minute presentation plus 5-10 minutes for questions.
2:15 pm – 2:45 pm	BREAK - (Foyer)
2:45 pm – 4:45 pm	PLENARY SESSION 6: Report on Breakouts – (Midway Ballroom) Chair: Dr. Graham Tipples, Public Health Agency of Canada
	Title	Speaker
	Key Challenges for the Front Lines of Public Health and Primary Care	Dr. Ken Scott, PHAC
	Specific public health and primary care strategies	Dr. Theresa Tam, PHAC
	Clinical Issues I: Diagnosis, Clinical Features and Antiviral therapy	Dr. Anand Kumar, University of Manitoba
	Clinical Issues II: Non-specific Support and Health Care Worker Issues	Dr. Anand Kumar, University of Manitoba
	Resource Utilization, Triage and Care Delivery	Dr. Joel Kettner, Manitoba Health
	Severe H1N1 Research: Critical Questions	Dr. Mike Drebot, PHAC
	20 minute presentation on recommendations per breakout/day.
4:45 pm – 5:00 pm	CLOSING REMARKS - (Midway Ballroom) Speaker: Dr. David Butler-Jones, Chief Public Health Officer, PHAC Dr. Frank Plummer, Chief Science Advisor, PHAC

BREAKOUT SESSIONS : West Ballroom

1. Key Challenges for the Front Lines of Public Health and Primary Care
   Chair: Dr. Ken Scott, Public Health Agency of Canada
   (8:30 am – 10:00 am)
   

1. Remote Communities – Dr. Marcus Lem, Health Canada
   Session will provide an overview of the key challenges faced by remote communities in preventing severe diseases and minimizing deaths, including challenges such as isolation, transportation, and application of current recommendations/guidelines that are mainly aimed at urban centres.
2. Public health challenges – Dr. Bonnie Henry, British Columbia Centre for Disease Control
   Session will provide an overview of the key challenges faced by public health in preventing severe diseases and minimizing deaths, including challenges in application of current recommendations/guidelines on public health /community mitigation measures and public communications.
3. Challenges for primary care – Dr. Jim Dickinson, University of Calgary
   Session will provide an overview of the key challenges faced by primary care in the early diagnosis and provision of early treatment of persons at increased risk for severe disease, including challenges in program implementation and application of current recommendations/guidelines.

2. Specific Public Health and Primary Care Strategies
   Chair: Dr. Theresa Tam, Public Health Agency of Canada
   (10:30 am – 12:00 pm)

1. Vaccines and vaccine deployment – Dr. Horacio Arruda, Quebec Ministry of Health and Social ServicesSession will provide current thinking on the Canadian vaccine strategy, prioritization of vaccine supply, vaccine effectiveness evaluation, monitoring and reporting of adverse events following immunization.

2. Antiviral strategies – Dr. Gerald Evans, Queens University
   Session will provide current recommendations on early antiviral treatment strategy, targeted post-exposure prophylaxis, implementation considerations, effectiveness evaluation, monitoring and reporting of adverse events.

3. Special populations: the high risk and the hard to reach – Dr. Marcia Anderson,
   Manitoba Health Session will include an overview on the key challenges/considerations and practical solutions to address the needs of specific high risk groups (pregnant women, those with chronic medical conditions etc.) and hard to reach populations (remote and isolated communities, aboriginal communities in urban areas, other vulnerable populations).

BREAKOUT SESSIONS : Midway Ballroom

Objectives:

1. Clinical Issues I: Diagnosis, Clinical Features and Antiviral Therapy
   Chair: Dr. Anand Kumar, University of Manitoba
   (8:30 am – 10:00 am)
   
   This session will focus on diagnostic, clinical and specific therapy issues specific to novel swine origin H1N1 severe infections as seen in Canada. In particular, presenters have been tasked with focusing on the differences seen in this epidemic infection in comparison to accepted and/or standard views of influenza.

1. Diagnosis: lessons learned – current recommendations vs clinical reality
   – Dr. Paul Van Caeseele, Manitoba Health

2. Pulmonary manifestations of severe H1N1 disease – Dr. Clare Ramsey, U of M

3. Non-pulmonary aspects of severe influenza – Dr. Kendiss Olafson, U of M

4. Antiviral therapy – Dr. Fred Aoki, U of M

2. Clinical Issues II: Specific Management
   Chair: Dr. Anand Kumar, University of Manitoba
   (10:30 am – 12:00 pm)
   
   This session will focus on issues of supportive and non-specific therapy of severe infection and nosocomial transmission/health care worker risk management. Presenters have been asked to emphasize aspects unique to the current outbreak.

   1. Supportive management strategies for severe swine origin H1N1 Pneumonitis
      – Dr. Faisal Siddiqui, U of M

   2. Adjunctive therapies – what do you have left when oseltamivir fails
      – Dr. Anand Kumar, U of M

   3. Health Care Workers and Nosocomial transmission – is the risk real?
      – Dr. Lynn Johnston, Dalhousie University

   4. Exposure and Prophylaxis: HCW issues – Dr. Lynn Johnston, Dalhousie University

BREAKOUT SESSIONS : East Ballroom

1. Resource Utilization, Triage and Care Delivery
   Chair: Dr. Joel Kettner, Manitoba Health
   (8:30 am – 10:00 am)
   
   This session will deal with medical ethics, clinical care guidelines, models of care delivery
   and regional cooperation.

1. Clinical Care Guidelines: From Evidence to Practice – Dr. Amin Kabani, PHAC

2. Triage: Public Health Ethics and Medical Ethics – Dr. Laura Hawryluck, Toronto General Hospital/UHN

3. Triage: When the rubber meets the road: Who goes first? – Dr. Mike Christian,
   Mount Sinai Hospital

4. Severe H1N1: Triage and Delivery of Adult Emergency Room Care
   – Dr. Ricardo Lobato de Faria, Seven Oaks General Hospital

5. Severe H1N1: Triage and Delivery of Pediatric Out Patient and Emergency Room Care
   – Dr. Lynne Warda, The Manitoba Institute of Child Health

6. Challenges in Models of Primary Care Delivery – Dr. Bruce Martin, U of M

7. Surveillance: Regional Coordination and Cooperation – Dr. Lisa Richards, Manitoba Health

2. Severe H1N1 Research: Critical Questions
   Chair: Dr. Mike Drebot, Public Health Agency of Canada
   
   This session will focus on various research themes concerning H1N1 infection and severe disease (10:30 am – 12:00 pm)

   1. Lessons from animal models – Dr. Gary Kobinger, PHAC

   2. Epidemiologic unknowns in H1N1 infection – Dr. Carole Beaudoin, PHAC

   3. Vaccines and Antivirals in the community – Dr. Barb Law, PHAC

   4. Therapeutics of severe H1N1 disease – Dr. Eleanor Fish, University of Toronto